1
|
Kaivers J, Lauseker M, Hildebrandt B, Fenaux P, Pfeilstöcker M, Valent P, Platzbecker U, Latagliata R, Oliva EN, Xicoy B, Götze K, Ganster C, Haase D, Bug G, Kündgen A, Gattermann N, Haas R, Germing U. The IPSS-R has prognostic impact in untreated patients with MDS del(5q). Leuk Res 2018; 72:27-33. [PMID: 30075323 DOI: 10.1016/j.leukres.2018.07.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2018] [Revised: 07/17/2018] [Accepted: 07/22/2018] [Indexed: 11/29/2022]
Abstract
The IPSS-R proved to be a powerful tool for the assessment of prognosis in MDS patients. We aimed at a validation of the IPSS-R for patients with MDS harboring deletion (5q) isolated or accompanied by additional aberrations. The study was based on 444 MDS patients from MDS centers in Europe. 67% of the patients were female, median age was 69 years. 43.5% had MDS del(5q), 5.9% were diagnosed with RCUD, 2.0% RARS, 18.4% RCMD, 14.6% RAEB-I and 15.5% RAEB-II. According to the IPSS-R, there were 9.9% very low, 39.6% low, 16.6% intermediate, 12.8% high, 20.9% very high risk patients. For very low risk patients survival was 7.5 years, low 9.0 years, intermediate 6.5 years, high 1.5 years and very high 0.7 years (p < 0.001). For low and intermediate risk, the probability of AML evolution was significantly different (p = 0.03) as well as for high versus very high risk groups (p = 0.002). The IPSS-R proved to be an appropriate prognostic tool for MDS with del(5q).
Collapse
Affiliation(s)
- J Kaivers
- Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany.
| | - M Lauseker
- Institute for Medical Informatics and Biometry, Ludwig-Maximilians-Universität, Munich, Germany
| | - B Hildebrandt
- Department of Human Genetics, University Hospital Düsseldorf, Germany
| | - P Fenaux
- Hôpital St. Louis, Université Paris 7, France
| | - M Pfeilstöcker
- Hanusch-Krankenhaus Vienna and L. Boltzmann Cluster Oncology, Vienna, Austria
| | - P Valent
- Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna and L. Boltzmann Cluster Oncology, Vienna, Austria
| | - U Platzbecker
- Department of Hematology and Oncology, University of Dresden, Germany
| | | | - E N Oliva
- Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
| | - B Xicoy
- Department of Hematology, Hospital Germans Trias i Pujol and Institut Català d'Oncologia-José Carreras Leukemia Research Institute, Badalona, Spain
| | - K Götze
- Department of Hematology and Oncology, Technical University of Munich, Munich, Germany
| | - C Ganster
- Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Germany
| | - D Haase
- Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Germany
| | - G Bug
- Department of Medicine, Hematology/Oncology, University Hospital, Frankfurt, Germany
| | - A Kündgen
- Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany
| | - N Gattermann
- Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany
| | - R Haas
- Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany
| | - U Germing
- Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany
| |
Collapse
|
2
|
Garderet L, Ziagkos D, van Biezen A, Iacobelli S, Finke J, Maertens J, Volin L, Ljungman P, Chevallier P, Passweg J, Schaap N, Beelen D, Nagler A, Blaise D, Poiré X, Yakoub-Agha I, Lenhoff S, Craddock C, Schots R, Rambaldi A, Sanz J, Jindra P, Mufti GJ, Robin M, Kröger N. Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion. Biol Blood Marrow Transplant 2018; 24:507-513. [DOI: 10.1016/j.bbmt.2017.11.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 11/12/2017] [Indexed: 01/22/2023]
|